vTv Therapeutics Inc. (VTVT)
Symbol Info
Listed Symbol VTVT
Name vTv Therapeutics Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $12,434,000
Latest Fiscal EPS $-0.72
Price Info
21 Day Moving Average $1.3511
21 Day EMA $1.345490
50 Day Moving Average $1.3857
50 Day EMA $1.409170
200 Day EMA $1.803050
200 Day Moving Average 1.874160
52 Week High $6.09
52 Week Low $0.68
52 Week Change $19.963600
Alpha 0.033102
Beta -3.5410
Standard Deviation 0.407789
R2 0.101370
Periods 49
Share Information
10 Day Average Volume 192,077
20 Day Average Volume 197,099
30 Day Average Volume 272,971
50 Day Average Volume 415,124
Outstanding Shares 55,345,245
Float Shares 55,214,131
Percent Float 99.76%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 79
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months 79,708
Institute Holdings Percent 12.700000
Institute Sold Previous 3 Months 70,431
Insider Holdings Date 2019-07-31
Insider Bought Previous 3 Months 1,358,700
Insider Holdings Percent 0.20%
Insider Sold Previous 3 Months -
Insiders Shares Owned 131,114
Price Change
7 Day Price Change $-0.0404
7 Day Percent Change -2.97%
21 Day Price Change $-0.0604
21 Day Percent Change -4.38%
30 Day Price Change $-0.2304
30 Day Percent Change -14.86%
Month To Date Price Change $-0.0804
Month To Date Percent -5.74%
90 Day Price Change $-0.3304
90 Day Percent Change -20.02%
Quarter To Date $-0.1104
Quarter To Date Percent -7.72%
180 Day Price Change $-1.0504
180 Day Percent Change -44.32%
200 Day Price Change $-1.4904
200 Day Percent Change -53.04%
Year To Date $-1.3304
Year To Date Percent -50.20%
Profile
Description vTv Therapeutics Inc operates in the United States healthcare sector. Its key business includes the development of orally administered small molecule drug candidates for the treatment of neurological disorders such as Alzheimer's disease. Its major drug candidate to treat Alzheimer's is azeliragon (TTP488), an orally administered drug. Its other products include TTP399, type II diabetes drug candidate. TTP399 is also an orally administered drug that targets the glucagon-like peptide-1 receptor. It also has over three additional programs in various stages of clinical development for the prevention of muscle weakness and the treatment of inflammatory disorders.
Details
Issue Type CS
Market Cap $73,033,585
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding 55,345,245
CEO Stephen L. Holcombe
Employees 52
Last Audit UE
Classification
CIK 0001641489
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 4170 Mendenhall Oaks Parkway
High Point, NC 27265
Website http://www.vtvtherapeutics.com
Facisimile +1 336 841-0310
Telephone +1 336 841-0300
Email IR@vtvtherapeutics.com
Key Ratios
Profitability
EBIT Margin -99.4
EBITDA Margin -97.9
Pre-Tax Profit Margin -7,535.2
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $10,646,000
Revenue Per Share $0.1924
Revenue 3 Years $147.11
Revenue 5 Years $52.62
Valuation Measures
PE Ratio -
Enterprise Value $79,282,008
Price To Sales 6.860190
Price To Free Cash -3
PE High Last 5 Years -
Price To Book -
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book -1.4
Financial Strength
Total Debt To Equity -
Int Coverage -3.9
Current Ratio 0.2
Leverage Ratio -0.2
Quick Ratio 0.2
Long Term Debt To Capital -
Assets
Receivables Turnover 1.7
Invoice Turnover -
Assets Turnover 0.20
Management Effectiveness
Return Assets -112.24
Return On Equity 18.75
Return On Capital -
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
VTVT
vTv Therap..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.